Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So our new drug that gives a small population of doomed children a chance at life, only sold about as many doses as last quarter.
Everyone knew it was a small patient population and another important test of the success of our anti-sense platform.
As a reward, the SP plummets 10%!..A genuinely chicken-ship reaction from the market
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Stochastic Analysis
Technical Indicators and Signals
The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) for the period of 9-Day stands at 91.68% while the stochastic %D for the same period stands at 90.12%.
The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.
Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) while 20-100 Day MACD Oscillator
“Buy”.
http://www.stocksmarketnews.com/ionis-pharmaceuticals-inc-nasdaqions-stochastic-analysis/
So, let's see....
IONS announces a new clinical trial series for a drug that might command enormous , unserved markets;
Collects a fat wad of dollars,
and the PPS sinks over # 3%.
Riiiight! Rational market indeed.
"CARLSBAD, Calif., Oct. 13, 2017 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that it has initiated a Phase 1/2a clinical study of IONIS-MAPTRx in patients with mild Alzheimer's disease (AD). Ionis earned a $10 million milestone payment from Biogen related to the initiation of this study."
Thanks Capecod.
If you want to be on a large board for ionis go to investor village and start posting on the public board there for ionis and then after a while ask if they will let you onto the private board. They let some people on and not others. You would be surprised how much posting they have on the private board and even the public one there has more than here.
That would explain the paucity of postings.
Please let me know if you find one Capecod.
( i'm not far from Big Sur on the other side of the continent.)
Is there a private board on this platform that has more ionis followers? There are a large number of followers and daily postings on a private board at investor village. Would like to join a similar board if there is one on this platform.
And between us we darn near own this board..grin.
I like this company too.
Thanks for the updates Thoro;
Ions has done quite nicely for me over the long run,
and with their promisingly fat pipeline
i'm sure to let it ride.
IONS, AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency
https://ih.advfn.com/p.php?pid=nmona&article=75321782
Ionis Pharmaceuticals reports phase 1/2 clinical study results with AKCEA-ANGPTL3-L
http://www.reuters.com/article/brief-ionis-pharmaceuticals-reports-phas-idUSFWN1IR0BI
Ionis Pharmaceuticals presents new data at peripheral nerve society meeting to support potential benefit of Inotersen
IONS
http://www.reuters.com/article/brief-ionis-receives-10-mln-milestone-pa-idUSASB0B97F
Ionis receives $10 mln milestone payment from Biogen
http://www.reuters.com/article/brief-ionis-receives-10-mln-milestone-pa-idUSASB0B97F
IONS
Reuters info on Ionis:
http://www.reuters.com/finance/stocks/overview?symbol=IONS.O
Another successful Ph 3 clinical trial result...
"The clinically meaningful benefit in quality of life bring a new energizing level of hope to the amyloidosis community around the world, a community whose critical needs have not been sufficiently addressed," said Isabelle Lousada, president and chief executive officer of the Amyloidosis Research Consortium (ARC)."
And again, the PPS sinks 4%!!!!
WTH ?!?!
I wish we had an effective SEC and less parasites gaming the market!
Not gonna happen in this era of deregulation.
But i'm buying more just to spite them. This is a great company with an enormous pipeline.
7:47 am ET
*Ionis Pharma Reports Earning of $50M Milestone Payment from Biogen Following EC Marketing Authorization for SPINRAZA
Benzinga
7:30 am ET
SPINRAZA(R) (Nusinersen) Approved in the European Union as First Treatment for Spinal Muscular Atrophy
BusinessWire
I don't understand why we are only up 6%?
Yeah, right...You shorts sure can get ugly.
If you did a bit of DD you'd know that in the second half of the trial a new protocol was put in place that prevented the negative outcomes...period.
I bought more.
Now the EU has just granted marketing authorization for this life saving drug for children
Ions down today 9% despite the big PH 3 TTR study meeting primary endpoints.
They had to add monitoring of negative side effects because of 3 deaths part way through. Once that was in place, no more serious problems.
This is the only effective treatment for TTR, an inherited disease that leads to an early death in childhood.
AF tweeted based on the early adverse reactions and drove the price down
I'd guess the FDA pretty much has to approve it.
So now would be an excellent time to pick up more shares...I will.
Chalk up a major point for IONS!
"
Biogen's SPINRAZA(R) (nusinersen) Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy"
$IONS and $OMER - For growth investors there are two great stocks out there in the biotech sector, according to experts:
Quick funadamental Analysis in this rticle below...
http://mytradingbuddy.com/markets-analysis/my-trading-buddy-markets-analysis-stocks/biotech-stocks-growth-investment/
It's about to get much worse with the new administration and deregulation.
I've been wondering if the prudent thing isn't to get out of the market entirely?
We are a smallish emerging bio,
we expect to yoyo around.
Looks like a buying opportunity to me.
I don't know the answer Percival;
In general, of they can make an oral formulation work, they will.
But i bet they are trying to think their way around it now!
They sell, we buy , now while it's really cheap.
We have a massive pipeline, a passel of BP partnerships,
now, all we need is patience.
Shorts must be leaking their fingers!!
I believe Goldman Sachs is Shorting this Stock!! Lets remember that the US government recently punnished Goldman Sachs for shorting and profiting during the recent recession!!
Wall-Street is full of crooks!!
Must be painful with the losses to many Longs!!
So does Golman Sach's rating mean that we gonna hit $25???
Is injection the only safe way to use whatever that treatment
is!!??
Goldman Sach's Cut to Sell did not help neither!!
Still beating us up over 5 injection site reactions. Down about 20% all told.
Can some knowledgeable I Hub member tell us if there's a technique to control injection site reactions?
Topical steroids? Multiple smaller injections? etc.
The Pivotal Ph3 results on volanesorsen are in and look pretty good.
Met it's primary endpoints and showed dramatic positive results.
..There were 5 drop outs, but nothing fatal and the more serious ones manageable.
The press seems to be playing it as negative and we dropped 7%...Makes no sense to me.
Up 10% today after settling for quite a while, with a few bumps up..
But we have a drug on the market now, a HUGE advanced pipeline, very active and successful R&D programs and partnerships and collaborations with numerous BP outfits.
This is an excellent long term bet!
I'd preen and strut with you admiring our good taste if some of my other bios weren't doing so dismally.
They are all gambles, but IONS vast pipeline sure helps spread the bets.
We are headed to beyond$50!
Biogen would not be putting $5Milions here if they didn't see the Huge Potential in IONS.
$$$$IONS$$$$
Good to know and Smart Judgement!!
I own IONS too!!
High Potential here!!
Other Huge Pharmas ....for example--BIOGEN see the Value in IONS,,hence,,we should too!!
$$IONS$$
I sure do, and have for a long time.
Hard to beat the pipeline and partnerships given the size of the company.
Very interesting, Thanks Xena.
The open labs/knowledge sharing model here is really exciting and should bring about advances much faster, if a bit less profitably.
I'd love to see it applied to other major killers.
Thanx for the Info!!
Do you hold IONS???
$$$IONS$$$
?
]'/
Anyone wanting to discuss Biogen, Ionis, and Anti-Sense for CNS please see the Biogen board.
http://www.alsa.org/news/vision-express/articles/april2016/the-neuro-collaborative.html?utm_source=natlnewsletter&utm_medium=email&utm_campaign=april2016
I think we have hit the Bottom here at 41.71!!,,,
Now we gonna Run Back towards the 50s!!
$$$$IONS$$$$
WOW! You are right this is a POS!!!
No one takes him seriously,,,,Congress will govern the Country not him!!
The president elect is presently beating up on the drug companies.
Typically, we slump between positive news announcements for IONS...
We are headed to hitting the 52 Week high of $57 in the next few days!!
$$$$$IONS$$$ Monster Pharmaceutical!!
Shorts were trampled on by the powerful Bulls!!!
$$IONS$$
Hope we close above $50 this week!! Then 40s will be History for good!!
$$IONS$$
That sure helps Percival: In time i hope we will be well enough financed to advance drugs alone.
But with our big pipeline, we need them now.
Of course, with the "huge benefits" they take a huge bite of the proceeds.
Shrub!! However, the important thing is,,, right now IONS has more recognition by major Pharmaceutical Giants than never before!!
That comes with huge benefits!!
$$IONS$$
Followers
|
47
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
488
|
Created
|
02/21/06
|
Type
|
Free
|
Moderators |
Ionis Pharmaceuticals, Inc., through its drug discovery platform based on antisense technology, discovers and develops drugs that bind to RNA antisense technology. The company has commercialized its antisense drug and has 19 drugs in development. Ionis' drug development programs are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer. It licenses its drugs to partners prior to late-phase development and commercialization. The company and Alnylam Pharmaceuticals jointly own Regulus Therapeutics Inc., a company focused on the discovery, development, and commercialization of microRNA therapeutics. Ionis is the owner or exclusive licensee of approximately 1,600 issued patents worldwide. The company was founded in 1989 and is based in Carlsbad, California.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |